Insulin aspart (brand names Novolog[1] and Novorapid[2]) is a rapid-acting insulin produced by Novo Nordisk. It is generally taken at or shortly after mealtimes and has a typical duration profile of three to four hours. Novorapid is approved for insulin pump use as well as to be taken before meals through a syringe.